ACT antimalarial (infant oral powder)
Camosunate Paediatric Powder is an artemisinin-based combination therapy (ACT) containing artesunate and amodiaquine, formulated for infants below 1 year for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum.

Active ingredients
Each sachet contains: Amodiaquine 75 mg + Artesunate 25 mg (oral powder/granules).

Pack size
6 sachets.

How to use
Use only as directed by a healthcare professional. Follow the leaflet for preparation and dosing.

Storage
Store in a cool, dry place away from heat and moisture.